CYNTHIA TUFARELLA: Open Payments
NPI 1649584814 · ALEXANDRIA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$192 in 9 payments from 7 companies in 2025. Trend: 2023 $272 · 2024 $625 · 2025 $192
Food & beverage: $192
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $74 |
| Vanda Pharmaceuticals Inc. | 1 | $24 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| Noven Therapeutics, LLC | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Neos Therapeutics, LP | 1 | $14 |
Products named: VRAYLAR, HETLIOZ, CAPLYTA, Auvelity, Xelstrym, Jornay PM, Adzenys XR-ODT.
Industry payments across KY — which companies pay providers there.
